Shiru is a Biotech company based in Berkeley, California. It has raised $36M in total funding. Latest round: Series B.
Shiru funding overview
Shiru is a Biotech company based in Berkeley, California. Shiru has raised $36M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2024. The round record for Shiru runs through 2024; nothing later has been disclosed. Investors on record include S2G Ventures, CPT Capital, Lux Capital, Nourish Ventures, Meach Cove Capital, Y Combinator and 4 others. 10 distinct backers are named across the disclosed rounds.
Shiru at a glance
Total raised
$36M
Latest round
Series B
Latest round date
June 2024
Industry
Biotech
Headquarters
Berkeley, California
Notable investors
S2G Ventures, CPT Capital, Lux Capital, Nourish Ventures, Meach Cove Capital, Y Combinator, Emles Venture Partners, The W Fund
Frequently asked about Shiru funding
How much has Shiru raised?
Shiru has raised $36M in total disclosed funding across the rounds on record.
Who has invested in Shiru?
S2G Ventures, CPT Capital, Lux Capital, Nourish Ventures, Meach Cove Capital, Y Combinator are named among the investors backing Shiru.
What was the latest Shiru funding round?
The most recent disclosed round is a Series B, announced in June 2024.
Where is Shiru based?
Shiru is based in Berkeley, California.
What sector does Shiru operate in?
Shiru is tracked under Biotech from Berkeley, California, with $36M in disclosed funding.
When did Shiru last raise?
The last disclosed Shiru round closed in June 2024 at Series B.
Every Shiru figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Berkeley at a similar stage.
